Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

66results about How to "Higher than vitality" patented technology

Preparation method of lactococcus lactis product for expressing phenylalanine ammonialyase

The invention belongs to the field of biomedicine, and relates to a preparation method of a lactococcus lactis product for expressing phenylalanine ammonialyase. The method sequentially comprises the following steps of: 1) acquiring genes for expressing the phenylalanine ammonialyase; 2) connecting the genes for expressing the phenylalanine ammonialyase and expression vectors suitable for transforming lactococcus lactis to form recombinant expression vectors; 3) transforming the recombinant expression vectors into competent lactococcus lactis; 4) screening lactococcus lactis strains for obtaining efficiently expressed phenylalanine ammonialyase; 5) fermenting the lactococcus lactis strains, and inducing the expressed phenylalanine ammonialyase; and 6) drying the strains obtained by fermentation, wherein the culture medium used in the fermentation of the step 5) is obtained by mixing an intermediate culture medium and an M17 broth culture medium in a volume ratio of 4:6-6:4; and regulating the pH value to be between 6.5 and 7.5. By adopting the technical scheme, the viable count of the obtained lactococcus lactis strains and the specific activity of the phenylalanine ammonialyase are greatly improved, wherein the viable count can reach over 10<12>CFU/ml, and the specific activity can reach over 80U/g.
Owner:BEIJING TRI PRIME GENE PHARMA CO LTD

Preparation method of lactococcus lactis product expressing phenylalanine ammonia lyase

The invention belongs to the field of biological medicine, and relates to a preparation method of a lactococcus lactis product expressing phenylalanine ammonia lyase, and the method orderly comprises the following steps: 1) obtaining a gene which expresses phenylalanine ammonia lyase; 2) connecting the gene which expresses phenylalanine ammonia lyase with a expression vector which is suitable forlactococcus lactis transformation so as to form a recombinant expression vector; 3) transforming competent lactococcus lactis by the recombinant expression vector; 4) screening to obtain a lactococcus lactis strain which highly expresses phenylalanine ammonia lyase; 5) fermenting the lactococcus lactis and inducing the expression of phenylalanine ammonia lyase; 6) drying the obtained fermented strain; wherein the pH of the fermentation liquid is adjusted to be 6.0-6.5 before the induction of fermentation in step 5); the pH is adjusted to be 6.5-7.5 after the induction; the strain is continued to be cultured till the fermentation is finished. With the technical scheme of the invention, the living bacteria number of the obtained lactococcus lactis and the specific activity of phenylalanine ammonia lyase are greatly increased, wherein the former reaches up to above 1012 CFU / ml, and the later reaches up to above 80 U / g.
Owner:BEIJING TRI PRIME GENE PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products